Ketogenic Diet Alleviates Colitis By Reduction Of Colonic Group 3 Innate Lymphoid Cells Through Altering Gut Microbiome

Researchers studied whether a ketogenic diet (very low carb, high fat) could help treat colitis, a type of inflammatory bowel disease that causes painful inflammation in the colon. They used mice with chemically-induced colitis and compared three different diets: ketogenic, low-carbohydrate, and normal diets. The goal was to understand how different eating patterns might influence gut health and inflammation.

The study found that mice on the ketogenic diet had significantly less colitis inflammation compared to the other diet groups. The ketogenic diet worked by dramatically changing the gut microbiome - increasing beneficial bacteria like Akkermansia while reducing harmful bacteria like E. coli. These bacterial changes led to different metabolic byproducts that helped protect the intestinal barrier and reduced inflammatory immune cells called ILC3s in the colon.

What makes this particularly interesting is that the ketogenic diet's benefits were specifically tied to its unique effects on gut bacteria, not just carbohydrate restriction. When researchers transplanted gut bacteria from ketogenic diet mice into germ-free mice, those mice also showed protection against colitis, proving the microbiome changes were key to the anti-inflammatory effects.

This research suggests that ketogenic diets might offer a therapeutic approach for inflammatory bowel conditions through their powerful effects on gut bacteria and intestinal immunity. However, since this was an animal study, more human clinical trials are needed before recommending ketogenic diets specifically for IBD treatment in clinical practice.